rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-9-27
|
pubmed:abstractText |
The standard treatment for chronic hepatitis C patients infected with HCV genotype-2 is a combination of pegylated interferon alfa and ribavirin over a 24 week period. It is unclear if a shorter treatment duration is possible for patients showing a rapid virological response (RVR) without compromising the sustained virologic response (SVR) in Korea.
|
pubmed:commentsCorrections |
|
pubmed:language |
kor
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1738-222X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
341-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17898550-Adolescent,
pubmed-meshheading:17898550-Adult,
pubmed-meshheading:17898550-Aged,
pubmed-meshheading:17898550-Antiviral Agents,
pubmed-meshheading:17898550-Data Interpretation, Statistical,
pubmed-meshheading:17898550-Drug Therapy, Combination,
pubmed-meshheading:17898550-Female,
pubmed-meshheading:17898550-Genotype,
pubmed-meshheading:17898550-Hepacivirus,
pubmed-meshheading:17898550-Hepatitis C, Chronic,
pubmed-meshheading:17898550-Humans,
pubmed-meshheading:17898550-Interferon-alpha,
pubmed-meshheading:17898550-Male,
pubmed-meshheading:17898550-Middle Aged,
pubmed-meshheading:17898550-Polyethylene Glycols,
pubmed-meshheading:17898550-Recombinant Proteins,
pubmed-meshheading:17898550-Retrospective Studies,
pubmed-meshheading:17898550-Ribavirin,
pubmed-meshheading:17898550-Time Factors,
pubmed-meshheading:17898550-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
[Short-term therapy with pegylated interferon plus ribavirin for the chronic hepatitis C genotype 2 patients].
|
pubmed:affiliation |
Department of Internal medicine, Inje University College of Medicine, Paik Hospital, Busan, Korea.
|
pubmed:publicationType |
Journal Article,
English Abstract
|